Filing Details
- Accession Number:
- 0001209191-15-028872
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-24 17:14:52
- Reporting Period:
- 2015-03-20
- Filing Date:
- 2015-03-24
- Accepted Time:
- 2015-03-24 17:14:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1557421 | Ignyta Inc. | RXDX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1283290 | E Jonathan Lim | C/O Ignyta, Inc. 11095 Flintkote Avenue, Suite D San Diego CA 92121 | President, Ceo & Director | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-03-20 | 20,000 | $9.01 | 25,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 3,316,668 | Indirect | By City Hill Venture Partners I, LLC |
Footnotes
- Reflects the weighted average sale price of the shares purchased. 1,700 shares were purchased at $9.0076 per share and 18,300 shares were purchased at $9.0095 per share.
- The Reporting Person is the Manager of City Hill Ventures, LLC, which is the Manager of City Hill Ventures Partners I, LLC, and as such the Reporting Person and City Hill Ventures, LLC have the power to vote or dispose of the securities held of record by the Reporting Person and may be deemed to beneficially own those securities. The Reporting Person disclaims beneficial ownership of the securities held of record by the City Hill Venture Partners I, LLC except to the extent of his pecuniary interest therein.